@un-mptf-office.bsky.social🌍 Transparent, pooled finance breaks down silos and accelerates a just transition for all.
Ahead of the UN #ClimateSummit (#COP31), learn more about MPTFO-administered pooled funds.
#ClimateFinance #ClimateAction #UNMPTFO #UNGA81 #transitions
@jeanpierremora.bsky.socialA key word from UNICC during #UNGA81:
FOUNDATIONS. 🙌
#DigitalFoundations for a more efficient UN system.
Foundational AI capabilities for responsible adoption across the UN family.
Building the foundations for quantum readiness TODAY.
@corriehulse.bsky.socialDay 2 of #UNGA81 here we go! First coffee has been consumed, many more to go!
@toxicsfree.bsky.social🚨 Happening today!
Don't miss "Ending Lead Poisoning: A Global Call to Action" at 12:30 PM EST, where leaders and experts will share proven solutions and discuss how to implement them at scale to end this preventable crisis.
🎥 Watch: https://ow.ly/OzfN50ZPeQQ
@wmo-global.bsky.socialAt #UNGA81, WMO SG Celeste Saulo joined UN Partnerships #GoalsLounge to discuss preparing cities for extreme heat.
Agree in advance: 1) what threshold triggers action, 2) who acts, 3) who's reached first.
@clubdemadrid.bsky.social🌎 In the context of #UNGA81, the launch of the Future of International Cooperation 2026 report at the @rockefellerfdn.bsky.social brought global leaders together to reflect on how international cooperation can adapt to a rapidly changing geopolitical landscape.
@bastianbrauns.bsky.socialAre escalators working in New York, today? #UNGA81
@ippsecretariat.orgThank you for following along with today's event as part of @devex.com Impact House @ #UNGA81, and thank you to our host Rumbie Chakamba.
You can sign up to receive a recording of the event via Devex here: dvx.cm/bgxtab
@ippsecretariat.orgMalcolm Sowah: ''It's important that we maintain capabilities between crises. This means effective surveillance, clinical trial networks and regulatory readiness.''
@ippsecretariat.org''Industry want to be a part of the solution. Contracts need to be compatible with business requirements - legal and commercial obligations - happening right now with BDBV.'' - James Anderson, IFPMA
@ippsecretariat.org''Brazil's COVID response was based on existing institutions which requires sustained investment. A new biotech industry incl. fill & finish for vaccines - responds to Brazil's needs & can be used regionally, capacity allowing.'' - Priscila Ferraz Soares
@ippsecretariat.orgIFPMA's James Anderson on industry perspectives: ''Pandemic preparedness is insurance for the world. We all need it. Industry have supported the #100DaysMission since the beginning - expertise, products, science - to help the world prepare and respond to outbreaks''
@ippsecretariat.orgSowah continues: ''We also launched a Biological Security Strategy which complements the PPR strategy. We also have a cross-govt Board on 100DM. The 100 day goal can’t sit separately from national efforts on surveillance and manufacturing efforts”
@ippsecretariat.orgMalcolm Sowah of the UK Mission to the UN on UK progress: ''UK just launched PPR strategy which is the centre of this ambition to take rapid & coordinated action. It draws on COVID-19 and simulation exercise on PPR. Moving from preparing from one disease to many.''
@ippsecretariat.orgDr Priscila Ferraz Soares @fiocruz.bsky.social highlights: ''Brazil has launched new industrial policy focused on reducing external dependence, increasing mass production & new legislation on the health complex as a national asset for health security & innovation.''
@ippsecretariat.orgOur second panel session is on ''Delivering the 100 Days Mission: Preparedness in Practice''
Perspectives on embedding the 100 day goal in the strategies, policies & capabilities to enable rapid response w/ inputs from Fiocruz, IFPMA and the UK Mission to the UN.
@ippsecretariat.org@ippsecretariat.org@medicinespatentpool.org's Charles Gore comments: ''We need to have licenses in place and then triggered before a pandemic. Trying to put things in place interpandemic times to move as quickly as possible''
@ippsecretariat.orgOn BDBV, Sheila Mburu reflects on diagnostics availability: ''At Day 100 we still don’t have a true point-of-care test. This is essential for communities that don’t have access to centralised testing.''
@ippsecretariat.org@cepi.net's Dr Richard Hatchett on progress: ''The #100DaysMission is an aspiration, but BDBV is a perfect case to tell us how we’ve progressed towards it. We’re almost at Phase 1 trials. This is an example of Disease X in practice. 100DM is a multi year investment to get there.''